Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H The

Showing results (21-30 of 282) with videos related to

Pageof 29
Sort By:
Chest|February 1, 1979
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Class specific antibody response and in-vitro lymphocyte stimulation after primary immunization with Helix pomatia hemocyaninH M Jansen, T H The, N G Orie
The American Journal of Medicine|November 1, 1980
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenonC G Kallenberg, A A Wouda, T H The
Journal of Immunological Methods|November 26, 1982
A sensitive method to measure PHA-induced cytotoxicity to adherent target cells using [3H]uridine as a terminal labelW C Gadiot, P J Hoedemaeker, T H The
Scandinavian Journal of Immunology|July 1, 1985
Isolation of highly purified lymphocyte subsets for functional studies by means of an indirect rosette techniqueM van der Giessen, S Postma, T H The
The Netherlands Journal of Medicine|January 1, 1986
Raynaud's phenomenon: factors of prognostic significance for the development of connective tissue disease. Relevance of vascular and immunological testsC G Kallenberg, T H The, A A Wouda
The Netherlands Journal of Medicine|January 1, 1984
Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?C G Kallenberg, A A Wouda, T H The
Thorax|October 1, 1980
Adjuvant immunotherapy with BCG in squamous cell bronchial carcinomaH M Jansen, T H The, N G Orie
Clinical and Experimental Immunology|December 1, 1988
The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetenceH W Roenhorst, C G Kallenberg, T H The
Clinical and Experimental Immunology|September 1, 1980
Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppressionC G Kallenberg, G C de Gast, T H The
La Nouvelle Presse Medicale|December 2, 1978
[Raynaud's phenomenon, a paraneoplastic syndrome?]J Van der Meulen, T H The, A A Wouda
Pageof 29

Showing results (21-30 of 282) with videos related to

Sort By:
Pageof 29
Chest|February 1, 1979
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Class specific antibody response and in-vitro lymphocyte stimulation after primary immunization with Helix pomatia hemocyaninH M Jansen, T H The, N G Orie
The American Journal of Medicine|November 1, 1980
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenonC G Kallenberg, A A Wouda, T H The
Journal of Immunological Methods|November 26, 1982
A sensitive method to measure PHA-induced cytotoxicity to adherent target cells using [3H]uridine as a terminal labelW C Gadiot, P J Hoedemaeker, T H The
Scandinavian Journal of Immunology|July 1, 1985
Isolation of highly purified lymphocyte subsets for functional studies by means of an indirect rosette techniqueM van der Giessen, S Postma, T H The
The Netherlands Journal of Medicine|January 1, 1986
Raynaud's phenomenon: factors of prognostic significance for the development of connective tissue disease. Relevance of vascular and immunological testsC G Kallenberg, T H The, A A Wouda
The Netherlands Journal of Medicine|January 1, 1984
Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?C G Kallenberg, A A Wouda, T H The
Thorax|October 1, 1980
Adjuvant immunotherapy with BCG in squamous cell bronchial carcinomaH M Jansen, T H The, N G Orie
Clinical and Experimental Immunology|December 1, 1988
The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetenceH W Roenhorst, C G Kallenberg, T H The
Clinical and Experimental Immunology|September 1, 1980
Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppressionC G Kallenberg, G C de Gast, T H The
La Nouvelle Presse Medicale|December 2, 1978
[Raynaud's phenomenon, a paraneoplastic syndrome?]J Van der Meulen, T H The, A A Wouda
Pageof 29